Electromed

ELMD

Market cap $203M

From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.

Management will present Monday, October 20, 2025 at 10:00 am PT New Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced that Company management will participate in the LD Micro Main Event XIX Conference being held October 19-21, 2025 in San Diego. Electromed President and Chief Executive Officer Jim Cunniff will present on Monday, October 20 at 10:00 am PT.

Let's take a look at four stocks, AVO, ELMD, GLDD and CENX, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.

FUTU, LRN, CSW, AEM and ELMD have been added to the Zacks Rank #1 (Strong Buy) List on September 26, 2025.

Does Electromed, Inc. (ELMD) have what it takes to be a top stock pick for momentum investors? Let's find out.

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The mean of analysts' price targets for Electromed (ELMD) points to a 52.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Share Repurchase Authorization.

Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.

Electromed (ELMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.